Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 34,982 | 33,791 | 26,924 | 26,235 | 25,459 |
| Operating Income | -34,982 | -33,791 | -26,924 | -26,235 | -25,459 |
| Other Income | 3,402 | 6,136 | 2,173 | -20 | 2,954 |
| Pre-tax Income | -31,580 | -27,655 | -24,751 | -26,255 | -22,505 |
| Income Tax | 130 | 97 | 84 | 49 | 0 |
| Net Income Continuous | -31,710 | -27,752 | -24,835 | -26,304 | -22,505 |
| Net Income | $-31,710 | $-27,752 | $-24,835 | $-26,304 | $-22,505 |
| EPS Basic Total Ops | -0.41 | -0.41 | -0.43 | -0.49 | -0.56 |
| EPS Basic Continuous Ops | -0.41 | -0.41 | -0.43 | -0.49 | -0.56 |
| EPS Diluted Total Ops | -0.41 | -0.41 | -0.43 | -0.49 | -0.56 |
| EPS Diluted Continuous Ops | -0.41 | -0.41 | -0.43 | -0.49 | -0.56 |
| EBITDA(a) | $-34,558 | $-33,388 | $-26,532 | $-25,783 | $-25,013 |